( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Mohamed Ebsaim*, Talal Alharari, Hana Fahelbum, Husni Alraheem, Jamila Adeep, Ayiman Ahfeethah, Nihal Anbeeh, Hanadi Eshtab


Background: patients infected with SARS-CoV-2 develop potentially life-threatening pathologies involving hyper inflammation, cytokine storm, septic shock complications, coagulation dysfunction, and multiple organ failure. Laboratory biomarkers are effectively used for detecting disease severity and distinguishing between severe and non-severe COVID-19 cases to guide for best therapeutic options. Aim: to predict the incidence and severity of COVID-19 infection through the hematological, inflammatory and coagulation biomarkers in hospitalized and non-hospitalized patients. Materials and Method: in this retrospective cohort study, 114 patients with age ranging between 30-80 years who were diagnosed with COVID-19 positive were selected from Alnaser Isolation Center, Azawia/ Libya. Patients were classified into 49 severe or critically ill patients who admitted to the isolation center, and 65 non-sever group with or without regular symptoms. Results: among hospitalized COVID-19 patients, the levels of WBCs, NEU, CRP, ESR were increased significantly and lymphocytes were decreased significantly (P<0.001) in comparison to their levels in non-hospitalized patients. 10.8 % of non-hospitalized had high D-dimer level whereas, 67.3% of hospitalized patients their D-dimer level was abnormal and increased significantly (P<0.001). Regarding the age groups, only elderly patients (50-79 and ≥ 80 years age groups) showed a significant increase in CRP, ESR and D-dimer levels in both patient groups (P<0.05). Although, the mortality rate among all patients was 20.2%, this percentage increased in hospitalized patients and reached 42.9%. Non-survivors COVID-19 patients developed leukocytosis, neutrophilia and lymphopenia, along with abnormal values of D-dimer, CRP and ESR levels. Conclusion: an elevated serum WBC, NUE, ESR and CRP were associated with start of infection and severity COVID-19 with clearly low level of lymphocyte. Coagulation biomarkers play a crucial role in identifying COVID-19 infection severity and mortality.

Keywords: COVID-19 infection; Severity; Laboratory Biomarkers; Hospitalization; Morality; Survivors and Non-survivors.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2024 Issue has been Published, Kindly check it on


    MARCH 2024 issue has been successfully launched on MARCH 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia